Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-13

Clinical Trial Update: Suprachoroidal Administration in Subjects With Metastases to the Choroid [Phase 2]

View source ↗

Summary

Aura Biosciences is conducting a Phase 2 trial to evaluate suprachoroidal administration for metastases to the choroid (eye cancer). The study is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AU-011 (Belzupacap Sarotalocan)

Snippet

Sponsor: Aura Biosciences | Conditions: Eye Cancer, Primary Cancer | Phase 2 | Status: RECRUITING